Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

Belgium IBD Consortium, Cedars-Sinai IBD, International IBD Genetics Consortium, NIDDK IBD Genetics Consortium, NIHR IBD BioResource, Regeneron Genetics Center, SHARE Consortium, SPARC IBD Network, UK IBD Genetics Consortium

Research output: Contribution to journalArticlepeer-review

93 Scopus citations

Abstract

Genome-wide association studies (GWASs) have identified hundreds of loci associated with Crohn’s disease (CD). However, as with all complex diseases, robust identification of the genes dysregulated by noncoding variants typically driving GWAS discoveries has been challenging. Here, to complement GWASs and better define actionable biological targets, we analyzed sequence data from more than 30,000 patients with CD and 80,000 population controls. We directly implicate ten genes in general onset CD for the first time to our knowledge via association to coding variation, four of which lie within established CD GWAS loci. In nine instances, a single coding variant is significantly associated, and in the tenth, ATG4C, we see additionally a significantly increased burden of very rare coding variants in CD cases. In addition to reiterating the central role of innate and adaptive immune cells as well as autophagy in CD pathogenesis, these newly associated genes highlight the emerging role of mesenchymal cells in the development and maintenance of intestinal inflammation.

Original languageEnglish
Pages (from-to)1275-1283
Number of pages9
JournalNature Genetics
Volume54
Issue number9
DOIs
StatePublished - Sep 2022
Externally publishedYes

Funding

FundersFunder number
B. Hasso Family Foundation
Samsung Bioepis
Trans-ethnic Mapping of Mendelian and Complex Diseases5U01HG009080
UCB Biopharma
National Institutes of HealthR01HG010140, 5UM1HG008895, U54HG003067
National Human Genome Research Institute
National Institute of Diabetes and Digestive and Kidney DiseasesP30DK043351, K01DK114379
Eli Lilly and Company
Pfizer
Roche
Leona M. and Harry B. Helmsley Charitable Trust2015PG-IBD001
Takeda Pharmaceutical Company
Janssen Pharmaceuticals
Pfizer UK
Merck Sharp and Dohme
Wellcome Trust206194, 108413/A/15/D
Broad Institute
Gilead UK and Ireland Corporate Contributions
Hospira
Academy of FinlandR01DK104844, DK062420, DK062431, DK062432, P01DK046763, DK087694, 312074, R01DK111843, 336824, P01DK094779, K23DK117054, U01DK062413
NIHR Oxford Biomedical Research Centre

    Fingerprint

    Dive into the research topics of 'Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility'. Together they form a unique fingerprint.

    Cite this